Re:Triple Agonist Retatrutide Hits New Weight-Loss Highs
by YankeeDocNJ on Monday July 17, 2023 @04:59PM
(#36763997)
Within 5 years 20% of the population will be on them and it will be very cost effective in reducing the need for weight loss surgery, cardiac disease, and diabetes. Diabetes costs a TON of money in later years - it is a long term killer, and if we can keep 20% of adult onset diabetics from ever developing it that is really something!!!
[ Parent
| on HN ]
There are no comments on this comment yet.